Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

GSK agrees to pay up to $2.2 bln to settle about 80000 Zantac lawsuits

Written By Ruchika Sharma10 Oct 2024 6:17 PM IST

New York: Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S. state courts,...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

JnJ completes acquisition of V Wave

Written By Ruchika Sharma10 Oct 2024 12:34 PM IST

New Brunswick: Johnson & Johnson has announced that it has successfully completed the acquisition of V-Wave Ltd., a privately-held company...

Pfizer files second lawsuit against Metsera, its controlling stockholders, Novo Nordisk

Pfizer wins bid to invalidate 2 GSK patents relating to RSV vaccine

Written By Ruchika Sharma9 Oct 2024 2:33 PM IST

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held by GlaxoSmithKline (GSK)...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ to discontinue Phase 2 Field Study evaluating investigational antiviral for Dengue prevention

Written By Ruchika Sharma8 Oct 2024 4:50 PM IST

Raritan: Johnson & Johnson has announced it is discontinuing the Phase 2 field study (NCT05201794) evaluating the efficacy of investigational...

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

Boehringer Ingelheim gets USFDA Breakthrough Therapy designation for survodutide

Written By Ruchika Sharma8 Oct 2024 3:59 PM IST

Boehringer Ingelheim has announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for survodutide (BI...

WHO unveils new guideline to improve global access to controlled medicines

Cecolin: WHO adds HPV vaccine for single dose use

Written By Ruchika Sharma8 Oct 2024 12:30 PM IST

WHO announced that a fourth WHO-prequalified human papillomavirus (HPV) vaccine product, Cecolin has been confirmed for use in a single-dose schedule....

Sun Pharma unit Taro recalls over 17k units of antifungal medication in US

Medtronic voluntary recalls MiniMed 600 series or 700 series insulin pumps due to potential risks of shortened pump battery life

Written By Ruchika Sharma7 Oct 2024 2:00 PM IST

Galway: Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed 600 series or 700 series...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Lupin gets 5 USFDA observations for Pune biotech facility

Written By Ruchika Sharma7 Oct 2024 11:30 AM IST

Mumbai: Lupin has announced that the US Food and Drug Administration (U.S. FDA) has completed a Pre-Approval Inspection with five observations at...

Record sales of Rs 200 crore achieved by Jan Aushadhi Kendras in September

Written By Ruchika Sharma6 Oct 2024 2:15 PM IST

New Delhi: Record sales of Rs 200 crore were achieved by Jan Aushadhi Kendras under Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) in...

JnJ seeks USFDA nod for Darzalex Faspro-based quadruplet regimen for newly diagnosed multiple myeloma patients for whom transplant is not planned

Written By Ruchika Sharma6 Oct 2024 10:30 AM IST

Raritan: Johnson & Johnson has announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug...

Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from Europe

Shilpa Pharma Lifesciences receives CEP from EDQM for API, Desmopressin

Written By Ruchika Sharma6 Oct 2024 10:00 AM IST

Karnataka: Shilpa Medicare Limited's 100% subsidiary, Shilpa Pharma Lifesciences Limited has received certificate of suitability (CEP) from EDQM...

AstraZenecas Imfinzi Combo Shows Strong Survival Benefit in Liver Cancer Trial

Astrazeneca Calquence granted priority review by USFDA for previously untreated mantle cell lymphoma

Written By Ruchika Sharma5 Oct 2024 2:30 PM IST

Cambridge: AstraZeneca's supplemental New Drug Application (sNDA) for Calquence (acalabrutinib) has been accepted and granted Priority Review in...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok